A clinical evaluation of the classification of International Lymphoma Study Group non-Hodgkin’s lymphoma (1997) The non-Hodgkin’s lymphoma classification project. Blood 89:3909–18
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Rummel MJ, Niederle N, Maschmeyer G et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381:1203–10
Edwards-Bennett SM, Straus D, Athanasian EA, Yahalom J (2011) Extranodal MALT lymphoma of the right triceps muscle following influenza vaccine injection: a rare case with an interesting presentation. ISRN Hematol 2011:617293
Zinzani PL (2012) The many faces of marginal zone lymphoma. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2012:426–32